克癣膏3号抗真菌活性的实验研究

用试管内（ｉｎ ｖｉｔｒｏ）试验和癣病动物模型探讨克癣膏３号的抗真菌效果。结果表明：在试管内,克癣膏３号对供试的多种病原性真菌均有不同程度的抗菌活性;把石膏样毛癣菌接种到豚鼠背部皮肤上,造成实验性体癣模型,再在病灶部位外涂克癣膏３号,其对豚鼠实验性体癣也有较好的治疗效果。无论在试管内还是利用动物模型进行治疗实验,克癣膏３号的抗真菌活性均强于对照抗真菌药物水杨酸。     

须癣毛癣菌所致面部体癣继发癣菌疹1例

报道1例由须癣毛癣菌引起面部体癣后继发的癣菌疹。患者女,10岁,因右眶周红斑、鳞屑10 d就诊。鳞屑直接镜检查见菌丝,培养生长的菌落鉴定为须癣毛癣菌。内服特比萘芬、外用萘替芬酮康唑乳膏治疗8 d后面部及颈胸部出现片状红斑,考虑为癣菌疹,加服抗过敏、抗炎药物(左西替利嗪、复方甘草酸苷片)、外用卤米松/三氯生软膏14 d后皮损消退。     

石膏样毛癣菌LZY8905株所致体癣模型及其在药物研究中应用探讨

石膏样毛癣菌ＬＺＹ８９０５株是从临床分离的强毒株,将其接种到豚鼠背部皮肤上,造成实验性体癣模型,其发病过程和病变特点与国外报告基本一致。用克霉唑癣药水对其进行治疗实验,证明对其具有较好的疗效。由于目前国内尚乏对动物致病性较强的菌株用于动物造模,所以该菌株可用于动物体癣模型的造模,用于抗皮肤癣菌药物等方面的研究。     

须癣毛癣菌致人兔共患体癣3例

报道须癣毛癣菌引起的人兔共患体癣3例.患者皮损均为环状红斑丘疹,上覆鳞屑,炎症明显,伴瘙痒,均与兔子有密切接触史,且兔子均有明显皮损.取患者及兔子的皮屑真菌镜检及培养,鉴定为须癣毛癣菌,经口服及外用抗真菌药物后治愈.     

须癣毛癣菌致儿童脓癣1例

报道由须癣毛癣菌引起的儿童头部脓癣1例.患儿为4岁幼女,因头皮部丘疹1个月,脓肿4d就诊.内服青霉素V钾无效.取断发镜检查见发外真菌孢子,培养鉴定为须癣毛癣菌,细菌培养为棒状杆菌.经内服和外用特比萘芬抗真菌,静脉输入头孢噻肟钠联合克林霉素及万古霉素抗细菌治疗,12d后脓肿减轻,细菌培养阴转,但真菌培养仍阳性,继续抗真菌治疗2个月后皮损消退,真菌检查阴性.     

致脓癣的须癣毛癣菌鉴定及体外药敏试验

须癣毛癣菌是皮肤癣菌病中常见的致病真菌之一,其分型复杂,具有多个变种和有性型,引起脓癣的常为亲动物性分离菌。从形态学角度难以明确区分不同种型,需要从分子生物学角度加以鉴定。rDNA序列测定是目前最常用于真菌鉴定的一种方法。我们从一脓癣患儿头部分离出一株须癣毛癣菌,对其形态学、rDNA序列和体外对抗真菌药物的敏感性进行了研究。     

须癣毛癣菌分类进展

须癣毛癣菌以往被视为单一的菌种,然而随着形态学和分子生物学等试验的研究,逐步探索并明确须癣毛癣菌的菌间分类及有性型的关系.本文综述了须癣毛癣菌在亲宿主性、交配试验、形态学和生理学试验、及分子生物学试验所进行的研究.     

误诊2年的左上臂难辨认体癣1例

报道1例由须癣毛癣菌引起的难辨认体癣。患者女,45岁,左臂伸侧多处红斑、丘疹伴脱屑、瘙痒2a余。曾多次就医诊断不明,患处皮损取活检做病理检查倾向于＂银屑病＂但疗效不佳。刮取皮屑镜检见真菌菌丝,小培养见葡萄串状小分生孢子及螺旋菌丝,尿素酶试验阳性,毛发穿孔试验阳性,鉴定为须癣毛癣菌。经内服特比萘芬和外用萘替芬酮康唑乳膏治疗28d后皮损消退,复查真菌阴性。     

应用CLSI M38-A2方案测定须癣毛癣菌对抗真菌药物敏感性

目的:对我国代表地区须癣毛癣菌临床分离株作抗真菌药物敏感性测定,进一步验证CLSI的M38-A2方案.方法:选取我国南北方8个省市地区经表型和分子生物学鉴定的趾间型毛癣菌38株和苯海姆节皮菌6株,采用M38-A2方案测定氟康唑、伊曲康唑、伏立康唑、特比萘芬、灰黄霉素、联苯苄唑、环吡酮胺和阿莫罗芬等8种常见抗真菌药物的最小抑菌浓度(minimal inhibitory concentration,MIC).结果:氟康唑、伊曲康唑、伏立康唑、特比萘芬、灰黄霉素、联苯苄唑、环吡酮胺和阿莫罗芬对趾间型毛癣菌株的MIC值(μg/mL)范围分别为0.25-32、0.0312-1、0.0156-0.0625、0.000937-0.00781、0.0625-1、0.0312-2、1-2、0.00781-0.0625;对苯海姆节皮菌株的MIC值(μg/mL)范围分别为≥64、2、0.25-0.5、0.000937-0.00381、1、2-4、1-2、0.0312-0.0625.不同抗真菌药物对趾间型毛癣菌及苯海姆节皮菌的药敏有明显差别(P<0.001);趾间型毛癣菌和苯海姆节皮菌对伊曲康唑、灰黄霉素、环吡酮胺、伏立康唑和氟康唑的药敏差异有统计学意义,对特比萘芬、阿莫罗芬和联苯苄唑的药敏差异无统计学意义.结论:趾间型毛癣菌和苯海姆节皮菌之间对伊曲康唑、灰黄霉素、环吡酮胺、伏立康唑和氟康唑的药敏有明显差异.M38-A2方案有较好的重复性和稳定性,适合用来体外测定须癣毛癣菌对抗真菌药物的敏感性.     

复方盐酸特比萘芬凝胶抗皮肤癣菌感染的组织病理学疗效观察

目的通过病理学研究评估外用抗真菌药-复方盐酸特比萘芬凝胶对常见皮肤癣菌的抗炎和抗真菌疗效。方法采用须癣毛癣菌感染豚鼠皮肤,建立动物模型,用4种皮肤外用制剂治疗,通过考察豚鼠病变皮肤的恢复情况,比较复方盐酸特比萘芬凝胶的治疗效果。结果在治疗须癣毛癣菌感染豚鼠的皮肤真菌病方面,复方盐酸特比萘芬凝胶的疗效优于盐酸特比萘芬凝胶(P0.05)、曲安奈德益康唑乳膏(P0.01)和糠酸莫米松凝胶(P0.01)。结论复方盐酸特比萘芬凝胶对豚鼠皮肤须癣毛癣菌感染的治疗和预防复发效果较好。     

蒺藜中甾体皂苷对新生隐球菌生物膜形成的抑制作用

目的 观察蒺藜甾体皂苷类化合物TTS-12对新生隐球菌生物膜形成的影响,探讨其可能的作用机制.方法 光镜观察TTS-12对新生隐球菌生物膜生长形态的影响;MTT法观察TTS-12对新生隐球菌生物膜形成的影响;实时定量RTPCR观察不同浓度TTS-12对新生隐球菌细胞生物膜关键基因PMT4表达的影响.结果 经TTS-12处理的新生隐球菌生物膜结构更疏松,TTS-12可剂量依赖性地降低新生隐球菌生物膜生长动力学指标及PMT4基因表达水平(P＜0.01).结论 TTS-12可抑制新生隐球菌生物膜的形成.通过降低新生隐球菌PMT4基因表达可能是其抑制新生隐球菌生物膜的形成作用机制之一.     

Antifungal therapy of dermatophytosis in guinea pigs and congenitally athymic rats

Guinea pigs and athymic nude (RNU/RNU) rats were used to assess the efficacy of three orally administered antifungal agents — Tolciclate, Tolnaftate, and Ketoconazole — against Trichophyton mentagrophytes dermatophytosis. All three antifungal agents inhibited the test strain of T. mentagrophytes in vitro. Antifungal agents were tested in intervention (oral therapy started 5 days after challenge) or prophylaxis (oral therapy started 5 days before challenge) protocols. Oral treatment of dermatophytosis on guinea pig skin demonstrated that Tolciclate and Tolnaftate alleviated clinical symptoms and shortened the duration of the dermatophytosis, in comparison to nontreated controls. Assessment of antifungal efficacy in the guinea pig model was time consuming (30–35 days) and variability in the duration and severity of clinical symptoms on guinea pig skin was common.Oral therapy of chronically infected athymic rats demonstrated that Tolciclate, Tolnaftate, and Ketoconazole were effective antifungal agents in vivo. Obvious improvement in clinical symptoms of dermatophytosis (i.e. less erythema and fewer lesions) was evident with all three antifungal agents within 10 days of starting oral therapy. By day 20, athymic rats that were treated with either Tolciclate or Ketoconazole showed marked clinical improvement of the chronic dermatophytosis.Chronically infected athymic rats, which lack thymus matured T-cells, are a promising new model to evaluate the efficacy of antifungal agents by culture, histology, and visual observations of clinical symptoms.     

Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens

Group 1 CD1 molecules have been shown to present lipid and glycolipid Ags of mycobacteria to human T cells. However, a suitable animal model for the investigation of this component of antimycobacterial immunity has not yet been established. Previously, we found that guinea pigs express multiple isoforms of group 1 CD1 proteins that are homologous to human CD1b and CD1c. In this study, we show that CD1-restricted T cell responses can be generated in guinea pigs following immunization with lipid Ags from Mycobacterium tuberculosis. Splenic T cells from lipid Ag-immunized guinea pigs showed strong proliferative responses to total lipid Ags and partially purified glycolipid fractions from M. tuberculosis. These lipid Ag-reactive T cells were enriched in CD4-negative T cell fractions and showed cytotoxic activity against CD1-expressing guinea pig bone marrow-derived dendritic cells pulsed with M. tuberculosis lipid Ags. Using guinea pig cell lines transfected with individual CD1 isoforms as target cells in cytotoxic T cell assays, we found that guinea pig CD1b and CD1c molecules presented M. tuberculosis glycolipid Ags to T cells raised by mycobacterial lipid immunization. These results were confirmed using a T cell line derived from M. tuberculosis lipid Ag-immunized guinea pigs, which also showed CD1-restricted responses and cytolytic activity. Our results demonstrate that CD1-restricted responses against microbial glycolipid Ags can be generated in vivo by specific immunization and provide support for the use of the guinea pig as a relevant small animal model for the study of CD1-restricted immune responses to mycobacterial pathogens.     

Species differences in ciprofibrate induction of hepatic cytochrome p450 4A1 and peroxisome proliferation

Six species (CD-1 mouse, Fischer 344 rat, Syrian golden hamster, Duncan-Hartley guinea pig, half-lop rabbit and marmoset monkey) were treated orally with ciprofibrate, a potent oxyisobutyrate hypolipidaemic drug for 14 days. A dosedependent liver enlargement was observed in the mouse and rat and at the high dose level in the hamster. A marked dose-dependent increase in the 12-hydroxylation of lauric acid was observed in the treated mouse, hamster, rat, and rabbit, associated with a concomitant elevation in the specific content of cytochrome P-450 4A1 apoprotein, determined by an ELISA technique. Similarly, in these responsive species, an increase in mRNA levels coding for cytochrome P450 4A1 was observed. Lauric acid 12-hydroxylation was unchanged in the guinea pig and marmoset after ciprofibrate pre-treatment, and cytochrome P-450 4A1 was not detected immunochemically in liver microsomes from these latter species. In the untreated mouse, hamster, rat, and rabbit, the 12-hydroxylation of lauric acid was more extensive than the 11-hydroxylation, whereas in the guinea pig and marmoset the activity ratios were reversed, with 11-hydroxylation predominating. Peroxisomal fatty acid β-oxidation was markedly induced in the mouse, hamster, rat, and rabbit on treatment at the higher dose level (39-, 3-, 13- and 5-fold, respectively) and was slightly increased in the marmoset (2-fold), yet was unchanged in the guinea pig following treatment. In the marmoset the increase in peroxisomal β-oxidation was 3- to 4-fold at the high dose level; however, the dose levels used in the marmoset were 20 and 100 mg/kg as opposed to 2 and 20 mg/kg in the other species. The differences in the foregoing hepatic enzyme responses to ciprofibrate between the species examined in our studies indicate a specific pattern of enzyme changes in responsive species. In the responsive species (rat, mouse, hamster, and rabbit), cytochrome P-450 4A1 specific content and related enzyme activity were increased concomitant with elevated peroxisomal β-oxidation. By contrast, the marmoset and guinea pig lack the coordinate hepatic induction of peroxisomal and microsomal parameters and may be categorized as less responsive species. Accordingly, the rat hepatic responses to peroxisome proliferators cannot confidently be used to predict biological responses in primates, with obvious implications for the extrapolation of animal data to man.     

Effects of exogenous steroids on androgen receptors in fetal guinea pig brain

We treated pregnant guinea pigs on Day 50 of gestation with 10 mg testosterone propionate (TP), obtaining fetuses 2, 4, 8, or 18 h later as well as after 5 days of treatment. In a second group of pregnant guinea pigs, dihydrotestosterone propionate (DHTP), estradiol benzoate (E2B), progesterone (P), or cortisol was given 2 h before obtaining fetuses. Although TP treatment elevated fetal serum T (p less than 0.05), brain cytosolic androgen receptor (ARc) content was unchanged in fetuses of either sex. In female fetuses, nuclear androgen receptors (ARn) increased 10-fold in medial-basal hypothalamus (MBH) and preoptic area (POA) at 2 and 4 h (respectively) after treatment, while fetal male ARn content was unchanged. Maternal injection of other steroids (E2B, P, or cortisol, but not DHTP) significantly increased these hormones in the fetus 2 h later (p less than 0.05). Only androgens affected fetal androgen receptor (AR) content. While TP increased ARn in female MBH, DHTP decreased ARc in fetal anterior pituitary of both sexes. In this latter case, a metabolite of DHT may mediate the effects. We conclude that T crosses the guinea pig placenta and activates ARn in POA and MBH of female fetuses; male ARn appear to be maximally occupied by endogenous T. Steroids of other classes do not induce AR responses in fetal guinea pig brain. These AR changes may represent an initial cellular mechanism in brain sexual differentiation.     

Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis

We examined the therapeutic effect of a 1% cream preparation of NND-502, a novel topical antifungal agent, in a guinea pig tinea pedis model produced by infecting the plantar skin of guinea pigs with Trichophyton mentagrophytes. Animals developing tinea pedis were divided into two groups: an untreated control group and a treated group. In the latter group, after confirming infection had been established, the infected animals were topically treated with the NND-502 cream once daily for one week. The animals were reared in a clean environment free from exposure to exogenous dermatophytes. At one week (5 weeks post-infection), 6 weeks (10 weeks post-infection) and 16 weeks (20 weeks post-infection) after completion of the treatment, plantar skin samples were taken from a certain number of both groups of animals. The results demonstrated that all of the animals in the untreated control group and none of those in the treated group were culture-positive in this animal model of tinea pedis. The topical treatment with NND-502 achieved a mycological cure. Thus NND-502 can be considered a promising candidate as a new anti-dermatophytic agent for topical use.     

丁苯酞对豚鼠平喘作用的初步药效学观察

目的：初步探讨丁苯酞对豚鼠的平喘作用及机制。方法：本次研究分为离体气管平滑肌实验与动物整体实验两部分。在离体实验中制备豚鼠离体气管片,使用Ach、Hist使气管平滑肌收缩达到最大值后,按累积加药法加入丁苯酞,记录1、10、100 mg/L丁苯酞对痉挛气管平滑肌的解痉作用（n=10）。在整体实验中,取经筛选的豚鼠分为正常对照组、模型对照组、地塞米松组及丁苯酞高、低剂量组（n=8）,在吸入低浓度激发液（1% ACh：0.05% Hist=1：1）激发6次（每次10 s）的基础上,第7次吸入高浓度激发液（2% ACh：0.1% Hist=1：1）10 s,观测90 mg/kg、30mg/kg丁苯酞对哮喘豚鼠行为学以及血清NO、支气管肺泡灌洗液（BALF）中ET-1的影响。结果：1、10、100 mg/L的丁苯酞对ACh、Hist引起的离体痉挛状态的豚鼠气管平滑肌有显著的解痉作用（对Ach的解痉率为15.08 ±7.68、42.41 ±13.54、77.56 ±24.82;对Hist的解痉率为19.40 ±7.60、56.84 ±11.72、76.35 ±19.40）且呈一定的量效关系（P< 0.05,0.01）;在乙酰胆碱与组胺的引喘下,90 mg/kg、30 mg/kg丁苯酞能明显延长豚鼠的哮喘潜伏期（53.3 ±13.2、33.1 ±13.0）,改善哮喘行为学,降低血清NO（78.71 ±19.40、84.75 ±20.97）、支气管肺泡灌洗液（BALF）中ET-1（24.30 ±5.80、28.50 ±6.31）的含量（P < 0.05,0.01）。结论：丁苯酞具有一定的平喘作用,而缓解NO、ET-1异常升高是其作用机制之一。     

Active immunization with a synthetic fragment of pig inhibin alpha-subunit increases ovulation rate and embryo production in superovulated ewes but season affects its efficiency.

Two experiments were designed to determine the effects of active immunization against one of two synthetic peptides from humans (inhibin-like peptide) or pigs (inhibin alpha-subunit) on antibody titres, ovulation rate and embryo production in ewes superovulated with 16 U ovine FSH. In Expt 1, during the breeding season, 30 ewes were subdivided into three groups: group I served as the non-immunized control; group II was immunized against inhibin-like peptide (100 micrograms inhibin-like peptide equivalent, followed by three booster injections); group III was immunized against pig inhibin alpha-subunit conjugated to human serum albumin (96 micrograms for the primary administration and 46 micrograms for the booster). In Expt 2, the efficiency of immunization against pig inhibin alpha-subunit on ovarian response and embryo production was evaluated during the non-breeding season in two groups of ewes (n = 12): group IV was a non-immunized control; Group V was immunized against pig inhibin alpha-subunit. During the breeding season, the ewes immunized against pig inhibin alpha-subunit showed higher antibody titres compared with the group immunized against inhibin-like peptide (P < 0.01) and a significant increase in ovulation rate (12.1) compared with both the control (5.0; P < 0.05) and the inhibin-like peptide-immunized group (3.1; P < 0.01). Immunization against pig inhibin alpha-subunit increased transferable embryo yield 4.5-fold (6.7 versus 1.5; P < 0.01) and improved embryo quality (94.6 versus 40.6%; P < 0.01). During the non-breeding season, immunization against pig inhibin alpha-subunit enhanced ovulation rate from 2.6 in the controls to 9.4 (P < 0.01) but did not affect transferable embryo production (3.9 versus 2.1; P > 0.05) and significantly lowered their quality (54.1 versus 100%; P < 0.01). In conclusion, active immunization against pig inhibin alpha-subunit can improve superovulatory response during the breeding season, while it appears to be unable to increase embryo yield during the seasonal anoestrus.     

Evaluation of<Emphasis Type="Italic">in Vitro</Emphasis> antifungal activity of<Emphasis Type="Italic">N</Emphasis>-Benzylsalicylamide derivatives

A series of 65 derivatives of N-benzylsalicylamide was tested against eight potentially human pathogenic fungi by microdilution broth method modified according to M27-A standard. The majority of these compounds showed only weak in vitro antifungal activity. The most significant effect was observed against filamentous fungi Trichophyton mentagrophytes, Absidia corymbifera, and Aspergillus fumigatus while yeasts, in general, were less susceptible. N-(4'-Chlorobenzyl) salicylamides, N-(3',4'-dichlorobenzyl)-salicylamides, and partially N-benzylsalicylamides exhibited relatively high in vitro antifungal activity. The most efficient derivatives had MIC < or = 7.8 mumol/L against T. mentagrophytes. Regression analysis suggested an indirect relationship between MIC values and lipophilicity (log P).     

Formation of 6-Aminopenicillanic Acid, Penicillins, and Penicillin Acylase by Various Fungi

Several penicillin-producing fungi were examined for ability to produce 6-aminopenicillanic acid (6-APA) and penicillin acylase. 6-APA was found in corn steep liquor fermentations of Trichophyton mentagrophytes, Aspergillus ochraceous, and three strains of Penicillium sp. 6-APA was not detected in fermentations of Epidermophyton floccosum although penicillins were produced. 6-APA formed a large part of the total antibiotic production of T. mentagrophytes. The types of penicillins produced by various fungi were identified by paper chromatography, and it was found that all cultures produced benzylpenicillin. T. mentagrophytes and A. ochraceous showed increased yields of benzylpenicillin and the formation of phenoxymethylpenicillin in response to the addition to the fermentation medium of phenylacetic acid and phenoxyacetic acid, respectively. Washed mycelia of the three Penicillium spp. and two high penicillin-yielding strains of P. chrysogenum possessed penicillin acylase activity against phenoxymethylpenicillin. A. ochraceous, T. mentagrophytes, E. floccosum, and Cephalosporium sp. also had penicillin acylase activity against phenoxymethylpenicillin. Only two of the above fungi, T. mentagrophytes and E. floccosum, showed significant penicillin acylase activity against benzylpenicillin; in both cases it was very low. The acylase activity of A. ochraceous was considerably increased by culturing in the presence of phenoxyacetic acid. It is concluded that 6-APA frequently but not invariably accompanies the formation of penicillin, and that penicillin acylase activity against phenoxymethylpenicillin is present in all penicillin-producing fungi.